These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9840434)

  • 21. Systemic exposure to fluticasone MDI delivered through antistatic chambers.
    Elmallah MK; Khan Y; Hochhaus G; Shuster JJ; Hendeles L
    J Allergy Clin Immunol; 2011 Nov; 128(5):1113-5.e1-3. PubMed ID: 21783234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive simultaneous determination of ciclesonide, ciclesonide-M1-metabolite and fluticasone propionate in human serum by HPLC-MS/MS with APPI.
    Mascher HJ; Zech K; Mascher DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):84-92. PubMed ID: 18514597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of interaction between salmeterol and fluticasone propionate and its effect on quantitative accuracy of an LC/MS/MS assay in human plasma at low pg/mL concentrations.
    Carter SJ; Cápka V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):163-9. PubMed ID: 19010742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous quantification of beclomethasone dipropionate and its metabolite, beclomethasone 17-monopropionate in rat and human plasma and different rat tissues by liquid chromatography-positive electrospray ionization tandem mass spectrometry.
    Wang Y; Hochhaus G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):203-10. PubMed ID: 15135091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The determination of budesonide and fluticasone in human sputum samples collected from COPD patients using LC-MS/MS.
    Buscher BA; Jägfeldt H; Sandman H; Brust-van Schaik R; van Schaik F; Brüll LP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):6-11. PubMed ID: 22169057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a sensitive liquid chromatography/tandem mass spectrometry method for the determination of exemestane in human plasma.
    Ksycińska H; Buś-Kwaśnik K; Szlagowska A; Rudzki PJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1905-10. PubMed ID: 21641878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
    Brutsche MH; Brutsche IC; Munawar M; Langley SJ; Masterson CM; Daley-Yates PT; Brown R; Custovic A; Woodcock A
    Lancet; 2000 Aug; 356(9229):556-61. PubMed ID: 10950233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitive method for the determination of baclofen in plasma by means of solid-phase extraction and liquid chromatography-tandem mass spectrometry.
    Flärdh M; Jacobson BM
    J Chromatogr A; 1999 Jun; 846(1-2):169-73. PubMed ID: 10420608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of molsidomine and its active metabolite in human plasma using liquid chromatography with tandem mass spectrometric detection.
    Streel B; Ceccato A; Peerboom C; Zimmer C; Sibenaler R; Maes P
    J Chromatogr A; 1998 Sep; 819(1-2):113-23. PubMed ID: 9781417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of orally administered micronised fluticasone propionate.
    Falcoz C; Oliver R; McDowall JE; Ventresca P; Bye A; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():9-15. PubMed ID: 11140434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.
    Thorsson L; Edsbäcker S; Källén A; Löfdahl CG
    Br J Clin Pharmacol; 2001 Nov; 52(5):529-38. PubMed ID: 11736861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration.
    Möllmann H; Wagner M; Meibohm B; Hochhaus G; Barth J; Stöckmann R; Krieg M; Weisser H; Falcoz C; Derendorf H
    Eur J Clin Pharmacol; 1998 Feb; 53(6):459-67. PubMed ID: 9551705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated 96-well liquid-liquid back extraction liquid chromatography-tandem mass spectrometry method for the determination of ABT-202 in human plasma.
    Xu N; Kim GE; Gregg H; Wagdy A; Swaine BA; Chang MS; El-Shourbagy TA
    J Pharm Biomed Anal; 2004 Sep; 36(1):189-95. PubMed ID: 15351065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factorial design for the development of automated solid-phase extraction in the 96-well format for determination of tesaglitazar, in plasma, by liquid chromatography-mass spectrometry.
    Svennberg H; Bergh S; Stenhoff H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Apr; 787(2):231-41. PubMed ID: 12650747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct and fast determination of antiretroviral drugs by automated online solid-phase extraction-liquid chromatography-tandem mass spectrometry in human plasma.
    Koal T; Sibum M; Koster E; Resch K; Kaever V
    Clin Chem Lab Med; 2006; 44(3):299-305. PubMed ID: 16519602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive liquid chromatography-tandem mass spectrometry method for the determination of scutellarin in human plasma: Application to a pharmacokinetic study.
    Yulan S; Fang F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):1-5. PubMed ID: 16269273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated sample preparation for the determination of budesonide in plasma samples by liquid chromatography and tandem mass spectrometry.
    Kronkvist K; Gustavsson M; Wendel AK; Jaegfeldt H
    J Chromatogr A; 1998 Oct; 823(1-2):401-9. PubMed ID: 9818417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of itraconazole and hydroxyitraconazole in plasma by use of liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction.
    Vogeser M; Spöhrer U; Schiel X
    Clin Chem Lab Med; 2003 Jul; 41(7):915-20. PubMed ID: 12940518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of fluticasone propionate in human plasma by LC-MS/MS and its application in the pharmacokinetic study of nasal spray at clinical doses.
    Yamagata A; Adachi R; Yokokawa A; Furihata T; Shibasaki H
    Drug Metab Pharmacokinet; 2024 Feb; 54():100541. PubMed ID: 38150944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.